nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ALB—metabolic syndrome X	0.711	1	CbGaD
Vemurafenib—Etoricoxib—PTGS2—metabolic syndrome X	0.00379	1	CrCbGaD
Vemurafenib—Rigors—Metformin—metabolic syndrome X	0.00197	0.0876	CcSEcCtD
Vemurafenib—Pain in extremity—Metformin—metabolic syndrome X	0.00117	0.0519	CcSEcCtD
Vemurafenib—Infestation NOS—Metformin—metabolic syndrome X	0.000901	0.04	CcSEcCtD
Vemurafenib—Infestation—Metformin—metabolic syndrome X	0.000901	0.04	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000883	0.0392	CcSEcCtD
Vemurafenib—Oedema peripheral—Metformin—metabolic syndrome X	0.000796	0.0354	CcSEcCtD
Vemurafenib—Connective tissue disorder—Metformin—metabolic syndrome X	0.000794	0.0353	CcSEcCtD
Vemurafenib—Eye disorder—Metformin—metabolic syndrome X	0.000756	0.0336	CcSEcCtD
Vemurafenib—Cardiac disorder—Metformin—metabolic syndrome X	0.00075	0.0333	CcSEcCtD
Vemurafenib—Angiopathy—Metformin—metabolic syndrome X	0.000734	0.0326	CcSEcCtD
Vemurafenib—Mediastinal disorder—Metformin—metabolic syndrome X	0.000729	0.0324	CcSEcCtD
Vemurafenib—Chills—Metformin—metabolic syndrome X	0.000725	0.0322	CcSEcCtD
Vemurafenib—Malnutrition—Metformin—metabolic syndrome X	0.000704	0.0313	CcSEcCtD
Vemurafenib—Erythema—Metformin—metabolic syndrome X	0.000704	0.0313	CcSEcCtD
Vemurafenib—Dysgeusia—Metformin—metabolic syndrome X	0.000689	0.0306	CcSEcCtD
Vemurafenib—Myalgia—Metformin—metabolic syndrome X	0.000599	0.0266	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000595	0.0264	CcSEcCtD
Vemurafenib—Infection—Metformin—metabolic syndrome X	0.000571	0.0253	CcSEcCtD
Vemurafenib—Nervous system disorder—Metformin—metabolic syndrome X	0.000563	0.025	CcSEcCtD
Vemurafenib—Skin disorder—Metformin—metabolic syndrome X	0.000558	0.0248	CcSEcCtD
Vemurafenib—Hypotension—Metformin—metabolic syndrome X	0.000537	0.0238	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000523	0.0232	CcSEcCtD
Vemurafenib—Decreased appetite—Metformin—metabolic syndrome X	0.000499	0.0222	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000496	0.022	CcSEcCtD
Vemurafenib—Fatigue—Metformin—metabolic syndrome X	0.000495	0.022	CcSEcCtD
Vemurafenib—Constipation—Metformin—metabolic syndrome X	0.000491	0.0218	CcSEcCtD
Vemurafenib—Asthenia—Metformin—metabolic syndrome X	0.000412	0.0183	CcSEcCtD
Vemurafenib—Pruritus—Metformin—metabolic syndrome X	0.000406	0.0181	CcSEcCtD
Vemurafenib—Diarrhoea—Metformin—metabolic syndrome X	0.000393	0.0175	CcSEcCtD
Vemurafenib—Dizziness—Metformin—metabolic syndrome X	0.00038	0.0169	CcSEcCtD
Vemurafenib—Vomiting—Metformin—metabolic syndrome X	0.000365	0.0162	CcSEcCtD
Vemurafenib—Rash—Metformin—metabolic syndrome X	0.000362	0.0161	CcSEcCtD
Vemurafenib—Dermatitis—Metformin—metabolic syndrome X	0.000362	0.0161	CcSEcCtD
Vemurafenib—Headache—Metformin—metabolic syndrome X	0.00036	0.016	CcSEcCtD
Vemurafenib—Nausea—Metformin—metabolic syndrome X	0.000341	0.0152	CcSEcCtD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	4.71e-05	0.000179	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PLA2G4A—metabolic syndrome X	4.69e-05	0.000179	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—APOA1—metabolic syndrome X	4.65e-05	0.000177	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	4.65e-05	0.000177	CbGpPWpGaD
Vemurafenib—RAF1—Disease—APOE—metabolic syndrome X	4.65e-05	0.000177	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCL2—metabolic syndrome X	4.64e-05	0.000177	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—APOE—metabolic syndrome X	4.61e-05	0.000176	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PTGS2—metabolic syndrome X	4.61e-05	0.000176	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—LPL—metabolic syndrome X	4.61e-05	0.000176	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—TRIB3—metabolic syndrome X	4.6e-05	0.000175	CbGpPWpGaD
Vemurafenib—RAF1—Disease—APOA1—metabolic syndrome X	4.6e-05	0.000175	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—APOA1—metabolic syndrome X	4.56e-05	0.000174	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TNF—metabolic syndrome X	4.53e-05	0.000173	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IRS1—metabolic syndrome X	4.49e-05	0.000171	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—FABP4—metabolic syndrome X	4.48e-05	0.000171	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—G6PD—metabolic syndrome X	4.47e-05	0.00017	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	4.43e-05	0.000169	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CD36—metabolic syndrome X	4.38e-05	0.000167	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	4.36e-05	0.000166	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	4.32e-05	0.000165	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	4.32e-05	0.000165	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IGF1—metabolic syndrome X	4.27e-05	0.000163	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GCKR—metabolic syndrome X	4.26e-05	0.000162	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—LPA—metabolic syndrome X	4.26e-05	0.000162	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—APOB—metabolic syndrome X	4.25e-05	0.000162	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—HSD11B1—metabolic syndrome X	4.24e-05	0.000162	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IRS1—metabolic syndrome X	4.2e-05	0.00016	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IGF2—metabolic syndrome X	4.19e-05	0.00016	CbGpPWpGaD
Vemurafenib—RAF1—Disease—IRS1—metabolic syndrome X	4.15e-05	0.000158	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PLA2G4A—metabolic syndrome X	4.13e-05	0.000157	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	4.13e-05	0.000157	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—NAMPT—metabolic syndrome X	4.13e-05	0.000157	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	4.11e-05	0.000157	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—IRS1—metabolic syndrome X	4.11e-05	0.000157	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	4.1e-05	0.000156	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—LIPC—metabolic syndrome X	4.1e-05	0.000156	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GCK—metabolic syndrome X	4.1e-05	0.000156	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOA5—metabolic syndrome X	4.08e-05	0.000156	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APOC3—metabolic syndrome X	4.07e-05	0.000155	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—APOB—metabolic syndrome X	4.07e-05	0.000155	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PPARA—metabolic syndrome X	4.07e-05	0.000155	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	4.06e-05	0.000155	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—SERPINE1—metabolic syndrome X	4.06e-05	0.000155	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—LPL—metabolic syndrome X	4.05e-05	0.000154	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—INS—metabolic syndrome X	4.02e-05	0.000153	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	4e-05	0.000153	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL5—metabolic syndrome X	3.97e-05	0.000151	CbGpPWpGaD
Vemurafenib—RAF1—Disease—INS—metabolic syndrome X	3.97e-05	0.000151	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PLA2G4A—metabolic syndrome X	3.96e-05	0.000151	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCL2—metabolic syndrome X	3.96e-05	0.000151	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CETP—metabolic syndrome X	3.95e-05	0.000151	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—AGT—metabolic syndrome X	3.94e-05	0.00015	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—INS—metabolic syndrome X	3.94e-05	0.00015	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	3.93e-05	0.00015	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IGF1—metabolic syndrome X	3.89e-05	0.000148	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—LPL—metabolic syndrome X	3.89e-05	0.000148	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—NOS3—metabolic syndrome X	3.87e-05	0.000148	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—APOE—metabolic syndrome X	3.86e-05	0.000147	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CD36—metabolic syndrome X	3.85e-05	0.000147	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—APOA1—metabolic syndrome X	3.82e-05	0.000145	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	3.8e-05	0.000145	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—SCARB1—metabolic syndrome X	3.79e-05	0.000144	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—G6PD—metabolic syndrome X	3.78e-05	0.000144	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	3.73e-05	0.000142	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—SERPINE1—metabolic syndrome X	3.69e-05	0.000141	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	3.69e-05	0.000141	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—SREBF1—metabolic syndrome X	3.68e-05	0.00014	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—IL6—metabolic syndrome X	3.66e-05	0.000139	CbGpPWpGaD
Vemurafenib—RAF1—Disease—SERPINE1—metabolic syndrome X	3.65e-05	0.000139	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—SERPINE1—metabolic syndrome X	3.62e-05	0.000138	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—LPA—metabolic syndrome X	3.61e-05	0.000138	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GCKR—metabolic syndrome X	3.61e-05	0.000138	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PPARA—metabolic syndrome X	3.58e-05	0.000136	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—HMGCR—metabolic syndrome X	3.58e-05	0.000136	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GOT2—metabolic syndrome X	3.58e-05	0.000136	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NOS3—metabolic syndrome X	3.53e-05	0.000134	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	3.5e-05	0.000133	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NOS3—metabolic syndrome X	3.49e-05	0.000133	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	3.47e-05	0.000132	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—AGT—metabolic syndrome X	3.47e-05	0.000132	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOA5—metabolic syndrome X	3.46e-05	0.000132	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—FABP4—metabolic syndrome X	3.46e-05	0.000132	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	3.46e-05	0.000132	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NOS3—metabolic syndrome X	3.45e-05	0.000132	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	3.41e-05	0.00013	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—APOE—metabolic syndrome X	3.4e-05	0.000129	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—LIPC—metabolic syndrome X	3.38e-05	0.000129	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GCK—metabolic syndrome X	3.38e-05	0.000129	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—AKT1—metabolic syndrome X	3.37e-05	0.000129	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PPARG—metabolic syndrome X	3.36e-05	0.000128	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOC3—metabolic syndrome X	3.36e-05	0.000128	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	3.36e-05	0.000128	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—APOA1—metabolic syndrome X	3.36e-05	0.000128	CbGpPWpGaD
Vemurafenib—BRAF—Disease—TGFB1—metabolic syndrome X	3.33e-05	0.000127	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—AGT—metabolic syndrome X	3.32e-05	0.000127	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—AKT1—metabolic syndrome X	3.31e-05	0.000126	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—INS—metabolic syndrome X	3.3e-05	0.000126	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	3.29e-05	0.000125	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	3.28e-05	0.000125	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CETP—metabolic syndrome X	3.27e-05	0.000124	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—APOE—metabolic syndrome X	3.26e-05	0.000124	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—LEP—metabolic syndrome X	3.26e-05	0.000124	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	3.26e-05	0.000124	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—IL6—metabolic syndrome X	3.23e-05	0.000123	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	3.23e-05	0.000123	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—APOA1—metabolic syndrome X	3.22e-05	0.000123	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	3.22e-05	0.000123	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ABCA1—metabolic syndrome X	3.19e-05	0.000121	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—SLC2A4—metabolic syndrome X	3.19e-05	0.000121	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PTGS2—metabolic syndrome X	3.19e-05	0.000121	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PTGS2—metabolic syndrome X	3.16e-05	0.00012	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	3.13e-05	0.000119	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GGT1—metabolic syndrome X	3.09e-05	0.000118	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GOT1—metabolic syndrome X	3.09e-05	0.000118	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	3.04e-05	0.000116	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ALB—metabolic syndrome X	3.02e-05	0.000115	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—AKT1—metabolic syndrome X	2.98e-05	0.000114	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PPARG—metabolic syndrome X	2.96e-05	0.000113	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	2.95e-05	0.000113	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GOT2—metabolic syndrome X	2.95e-05	0.000113	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—G6PD—metabolic syndrome X	2.92e-05	0.000111	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IRS1—metabolic syndrome X	2.91e-05	0.000111	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—INS—metabolic syndrome X	2.9e-05	0.000111	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—NOS3—metabolic syndrome X	2.89e-05	0.00011	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	2.89e-05	0.00011	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	2.87e-05	0.000109	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—LIPC—metabolic syndrome X	2.87e-05	0.000109	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GCK—metabolic syndrome X	2.87e-05	0.000109	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—AKT1—metabolic syndrome X	2.86e-05	0.000109	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	2.85e-05	0.000109	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOC3—metabolic syndrome X	2.85e-05	0.000109	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GCKR—metabolic syndrome X	2.79e-05	0.000106	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—LPA—metabolic syndrome X	2.79e-05	0.000106	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—INS—metabolic syndrome X	2.78e-05	0.000106	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CETP—metabolic syndrome X	2.77e-05	0.000105	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL2—metabolic syndrome X	2.74e-05	0.000104	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	2.7e-05	0.000103	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IGF1—metabolic syndrome X	2.69e-05	0.000103	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOA5—metabolic syndrome X	2.67e-05	0.000102	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ALB—metabolic syndrome X	2.66e-05	0.000101	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	2.65e-05	0.000101	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTGS2—metabolic syndrome X	2.65e-05	0.000101	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	2.63e-05	0.0001	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	2.63e-05	0.0001	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APOB—metabolic syndrome X	2.62e-05	9.98e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	2.58e-05	9.83e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	2.57e-05	9.8e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TGFB1—metabolic syndrome X	2.56e-05	9.76e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SERPINE1—metabolic syndrome X	2.56e-05	9.74e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GGT1—metabolic syndrome X	2.55e-05	9.71e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GOT1—metabolic syndrome X	2.55e-05	9.71e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PLA2G4A—metabolic syndrome X	2.55e-05	9.71e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—NOS3—metabolic syndrome X	2.55e-05	9.7e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—IL6—metabolic syndrome X	2.51e-05	9.56e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	2.5e-05	9.53e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GOT2—metabolic syndrome X	2.5e-05	9.53e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—LPL—metabolic syndrome X	2.5e-05	9.53e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	2.48e-05	9.46e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NOS3—metabolic syndrome X	2.44e-05	9.3e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CD36—metabolic syndrome X	2.38e-05	9.06e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TGFB1—metabolic syndrome X	2.33e-05	8.89e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTGS2—metabolic syndrome X	2.33e-05	8.87e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—AKT1—metabolic syndrome X	2.32e-05	8.82e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TGFB1—metabolic syndrome X	2.3e-05	8.78e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TGFB1—metabolic syndrome X	2.28e-05	8.71e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	2.26e-05	8.6e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	2.23e-05	8.5e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	2.23e-05	8.5e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	2.23e-05	8.49e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—LIPC—metabolic syndrome X	2.21e-05	8.43e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GCK—metabolic syndrome X	2.21e-05	8.43e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPARA—metabolic syndrome X	2.21e-05	8.42e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOC3—metabolic syndrome X	2.2e-05	8.38e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOB—metabolic syndrome X	2.16e-05	8.24e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GOT1—metabolic syndrome X	2.16e-05	8.23e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GGT1—metabolic syndrome X	2.16e-05	8.23e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—AGT—metabolic syndrome X	2.14e-05	8.16e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CETP—metabolic syndrome X	2.13e-05	8.14e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	2.1e-05	8.02e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APOE—metabolic syndrome X	2.1e-05	7.99e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APOA1—metabolic syndrome X	2.07e-05	7.9e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—LPL—metabolic syndrome X	2.07e-05	7.87e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL6—metabolic syndrome X	2.06e-05	7.84e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	2.04e-05	7.79e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.98e-05	7.56e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CD36—metabolic syndrome X	1.96e-05	7.48e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.93e-05	7.36e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.93e-05	7.36e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—AKT1—metabolic syndrome X	1.9e-05	7.24e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL6—metabolic syndrome X	1.88e-05	7.17e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOB—metabolic syndrome X	1.83e-05	6.98e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPARG—metabolic syndrome X	1.83e-05	6.96e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPARA—metabolic syndrome X	1.82e-05	6.95e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—INS—metabolic syndrome X	1.79e-05	6.83e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	1.78e-05	6.79e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—AKT1—metabolic syndrome X	1.78e-05	6.79e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—AGT—metabolic syndrome X	1.77e-05	6.73e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL6—metabolic syndrome X	1.76e-05	6.7e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—LPL—metabolic syndrome X	1.75e-05	6.67e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—IL6—metabolic syndrome X	1.74e-05	6.62e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—AKT1—metabolic syndrome X	1.74e-05	6.61e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOE—metabolic syndrome X	1.73e-05	6.6e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—IL6—metabolic syndrome X	1.72e-05	6.56e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	1.72e-05	6.56e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	1.72e-05	6.56e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOA1—metabolic syndrome X	1.71e-05	6.52e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GGT1—metabolic syndrome X	1.67e-05	6.35e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GOT1—metabolic syndrome X	1.67e-05	6.35e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CD36—metabolic syndrome X	1.66e-05	6.34e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—AKT1—metabolic syndrome X	1.62e-05	6.18e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TGFB1—metabolic syndrome X	1.61e-05	6.15e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—AKT1—metabolic syndrome X	1.6e-05	6.1e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—AKT1—metabolic syndrome X	1.59e-05	6.05e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—NOS3—metabolic syndrome X	1.57e-05	5.99e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPARA—metabolic syndrome X	1.55e-05	5.89e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPARG—metabolic syndrome X	1.51e-05	5.75e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AGT—metabolic syndrome X	1.5e-05	5.7e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—INS—metabolic syndrome X	1.48e-05	5.64e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOE—metabolic syndrome X	1.47e-05	5.59e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOA1—metabolic syndrome X	1.45e-05	5.53e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTGS2—metabolic syndrome X	1.44e-05	5.48e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOB—metabolic syndrome X	1.41e-05	5.39e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	1.38e-05	5.24e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALB—metabolic syndrome X	1.36e-05	5.17e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—LPL—metabolic syndrome X	1.35e-05	5.15e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—AKT1—metabolic syndrome X	1.33e-05	5.07e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NOS3—metabolic syndrome X	1.3e-05	4.94e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CD36—metabolic syndrome X	1.28e-05	4.89e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPARG—metabolic syndrome X	1.28e-05	4.87e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—INS—metabolic syndrome X	1.25e-05	4.77e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL6—metabolic syndrome X	1.22e-05	4.63e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPARA—metabolic syndrome X	1.19e-05	4.55e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	1.19e-05	4.52e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—AKT1—metabolic syndrome X	1.17e-05	4.46e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AGT—metabolic syndrome X	1.16e-05	4.4e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALB—metabolic syndrome X	1.15e-05	4.38e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOE—metabolic syndrome X	1.13e-05	4.31e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—AKT1—metabolic syndrome X	1.12e-05	4.28e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOA1—metabolic syndrome X	1.12e-05	4.26e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NOS3—metabolic syndrome X	1.1e-05	4.19e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	1e-05	3.83e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPARG—metabolic syndrome X	9.86e-06	3.76e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—INS—metabolic syndrome X	9.67e-06	3.68e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALB—metabolic syndrome X	8.87e-06	3.38e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NOS3—metabolic syndrome X	8.48e-06	3.23e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	7.76e-06	2.96e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—AKT1—metabolic syndrome X	7.22e-06	2.75e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—AKT1—metabolic syndrome X	5.96e-06	2.27e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AKT1—metabolic syndrome X	5.05e-06	1.92e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AKT1—metabolic syndrome X	3.9e-06	1.49e-05	CbGpPWpGaD
